01.01.2015 Views

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ABSTRACTS – Symposia<br />

detection of genomic aberrants. Yet, despite the ability to<br />

pinpoint cancer phenotypes that correlate with disease and<br />

treatment outcomes, we are not much closer to determining<br />

how and why particular “omics” expression patterns lead<br />

to disease. Recently, significant evidence has shown that<br />

genomic aberrants such as copy number alterations, deletions,<br />

and single nucleotide variants are associated with<br />

cancers. For example, a set of deletions and gene amplifications<br />

on Chromosome 8 are associated with differentiation<br />

between the basal and luminal breast cancers. These cancer<br />

types have widely different treatment outcomes and survival<br />

prognoses, and show significantly different expression patterns<br />

at the transcriptome and proteome level. Determining<br />

the mechanisms by which these aberrations lead to cancers<br />

is a key goal for both diagnosis and improved treatment.<br />

Yet integration of knowledge across levels, from genome to<br />

transcriptome to proteome to phenotype is extraordinarily<br />

challenging.<br />

We describe an effort to unify “omics” data sets from<br />

human in mouse breast tumor models, and from TCGA<br />

samples now being analyzed via large scale proteomic methods<br />

within the CPTAC consortium headed by the NCI. We<br />

show how data can be unified and analyzed within a genome<br />

browser view to yield new insights about the relationship<br />

between cancer genomes, proteomes, and their resultant phenotypes.<br />

We illustrate with examples of previously unknown<br />

genes that appear involved in specific cancer phenotypes.<br />

79 Oncostatin M Interacts with ECM Components: Implications<br />

for Chronic Inflammation and Tumor Metastasis,<br />

RANDALL RYAN*, BRYAN MARTIN, LILIANA MEL-<br />

LOR, OWEN McDOUGAL, REED JACOB, CHERYL<br />

JORCYK, and JULIA OXFORD (Department of Biological<br />

Sciences, Department of Chemistry and Biochemistry,<br />

Biomolecular Research Center, Boise State University,<br />

Boise Idaho, 83725 USA; randyryan7@hotmail.com).<br />

Oncostatin M (OSM) is a proinflammatory cytokine that<br />

has been reported to promote a metastatic phenotype in cancer<br />

cells via its effects on cell migration, invasion and the EMT.<br />

The ECM has been reported to regulate the properties and<br />

activities of numerous cytokines and growth factors, as well as<br />

the behavior and properties of tumor cells. In the current study,<br />

OSM was observed to bind to ECM components, in vitro, in<br />

a pH dependent fashion. OSM bound to ECM was observed<br />

to be protected from cleavage by tumor associated proteases,<br />

when compared to unbound OSM. In addition, OSM bound to<br />

ECM was demonstrated to induce OSM signaling and target<br />

proteins in breast carcinoma cells that could be inhibited with<br />

an OSM neutralizing antibody. The data suggests that OSM<br />

bound to ECM may play an important role in the acquisition<br />

of chronic inflammation and provides additional evidence for<br />

the role of inflammatory processes in cancer.<br />

NIH/NCRR P20RR016454 and P20GM103408, NASA NNX10AN29A,<br />

ACS RSG-09-276-01-CSM, and Susan G Komen KG100513.<br />

Emerging and Re-Emerging<br />

Infectious Diseases<br />

Wednesday, 8:00 a.m. in DOUGLAS FIR 1 & 2<br />

80 Toxin Production by Methicillin Resistant Strains of Staphylococcus<br />

aureus (MRSA): The Effect of Antibiotics, DEN-<br />

NIS L STEVENS 1,2 *, AMY E BRYANT 1,2,3 , STEPHANIE<br />

HAMILTON 1,3 and YONGSHENG MA 1 ( 1 Department of<br />

Veterans Affairs Medical Center, 500 West Fort Street, Boise,<br />

Idaho 83702; 2 University of Washington School of Medicine,<br />

1959 NE Pacific St, Seattle WA 98195; 3 University of Idaho,<br />

Department of Life Sciences, PO Box 443051, Moscow, ID<br />

83844-305; dlsteven@mindspring.com).<br />

The emergence of MRSA has been associated with a<br />

variety of new types of infections which have been associated<br />

with the production of potent exotoxins. Specifically,<br />

the Panton-Valentine Leukotoxins (PVL), alpha hemolysin<br />

and staphylococcal toxic shock toxin-1 (TSST-1). Early in<br />

the course of the MRSA epidemic it was noted that 50%<br />

of patients with MRSA infections were being treated with<br />

antibiotics to which the organism was resistant. This was<br />

further associated with worse outcomes, prolonged hospitalization<br />

and death. We hypothesized that inappropriate<br />

antibiotics might not only delay definitive treatment but be<br />

associated with enhanced toxin production. We first determined<br />

the susceptibility of these strains to nafcillin, vancomycin<br />

and linezolid and performed growth curves using<br />

a rising gradient of antibiotics. Further, we then measured<br />

gene expression for alpha toxin, PVL and TSST-1 at inhibitory<br />

and sub-inhibitory concentrations of antibiotics. Nafcillin<br />

induced markedly increased gene expression for PVL,<br />

TSST-1 and alpha hemolysin in MRSA despite intrinsic<br />

resistance to this agent. Further, sub-inhibitory concentrations<br />

of nafcillin marked increased gene expression of these<br />

toxins in methicillin susceptible strains of S. aureus (MSSA)<br />

as well. Though linezolid also enhanced toxin gene expression,<br />

toxin production at the protein level was curtailed. In<br />

summary, antibiotic choices markedly affect the virulence<br />

of S. aureus.<br />

81 Yersinia pestis Ompx Virulence Factor and Role in Host<br />

Cell Attachment, Internalization, and Immune Modulation,<br />

ANNA M Kolodziejek 1 *, Scott A Minnich 1 ,<br />

Carolyn J Hovde 1 , and Gregory A Bohach 2<br />

( 1 School of Food Science, University of Idaho, 604 Rayburn<br />

Street, Moscow, Idaho 83844 -2<strong>31</strong>1; 2 Division of Agriculture,<br />

Forestry and Veterinary Medicine, Box 9800, Mississippi<br />

State University, Starkville, Mississippi 39762; akolodziejek@vandals.uidaho.<strong>edu</strong>).<br />

Yersinia pestis is the causative agent of plague. Multiple<br />

virulence determinants contribute to its highly efficient<br />

transmission and pathogenicity. Representatives of a large<br />

Enterobacteriaceae Ail/Lom family of outer membrane<br />

proteins (Omp) are found in the genomes of all pathogenic<br />

70

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!